Keywords: Sanofi. Genzyme, Isis Pharma, Vanda Pharma, Kynamro, Fanaptum, EMA, CHMP, HoFH, Schizophrenia

Makers of Kynamro and Fanaptum to appeal negative CHMP opinions

Article | 17 December 2012

Print This

French drug major Sanofi’s (Euronext: SAN) subsidiary Genzyme and US partner Isis Pharmaceuticals (Nasdaq: ISIS) have said they ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in